CD80 and neoplasm: A potential explanation for these opposing functions of PD-L1 expression for T cell activity has recently been proposed by Bromberg and coworkers who showed that exclusive in-cis-binding of PD-L1 promotes anti-tumor immunity, while engagement of CD80 and PD-L1 in-trans inhibits immune-responses (63).